10x Genomics (TXG) Inventory (2018 - 2026)

10x Genomics' Inventory history runs 9 years deep, the most recent figure standing at $53.5 million for Q1 2026.

• In Q1 2026, Inventory fell 28.41% year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $53.5 million (down 28.41% YoY), while the FY2025 annual figure was $56.3 million, down 32.21% from the prior year.
• Inventory came in at $53.5 million for Q1 2026 at 10x Genomics, down from $56.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $94.0 million in Q3 2024 to a low of $53.5 million in Q1 2026.
• A 5-year average of $75.3 million and a median of $78.6 million in 2022 frame the typical range for Inventory.
• Across the five-year window, Inventory jumped 65.42% in 2022 and tumbled 34.12% in 2025, its largest moves.
• 10x Genomics' Inventory stood at $81.6 million in 2022, then declined by 9.71% to $73.7 million in 2023, then increased by 12.75% to $83.1 million in 2024, then plunged by 32.21% to $56.3 million in 2025, then slipped by 5.07% to $53.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $53.5 million, $56.3 million, and $62.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison